- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06916910
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
April 1, 2025 updated by: First Affiliated Hospital of Fujian Medical University
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors: A Multicenter Retrospective Clinical Study
In this study, we plan to explore the risk factors closely related to the occurrence of urinary leakage after partial nephrectomy for renal hilum tumors through retrospective analysis of multicenter clinical data, thereby providing clinical guidance value for the prevention of postoperative urinary leakage.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China, 350005
- first hospital affiliated of Fujian medical university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing partial nephrectomy for renal hilum tumors
Description
Inclusion Criteria:
- CT or MRI angiography indicates a renal hilum tumor, and the patient has undergone partial nephrectomy;
- The Eastern Cooperative Oncology Group (ECOG) performance status score is between 0 and 1, and the age is between 18 and 75 years old;
- The clinicopathological data are complete;
- There is no infection, autoimmune disease, hematological disease, or other malignancies.
Exclusion Criteria:
- The patient has surgical contraindications;
- There are congenital malformations of the urinary system, obstructive nephropathy, or other diseases that seriously affect the function of the urinary system before surgery;
- The patient has received relevant treatments that may affect the results of this study, such as radiotherapy in the kidney area, a history of kidney surgery, etc.;
- There are tumors in both kidneys.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative urinary leakage
Time Frame: the postoperative perirenal drainage volume being greater than 50 ml for 7 consecutive days and the creatinine level of the drainage fluid being similar to that of urine(μmol/L), or postoperative urinary leakage being suspected by imaging examination.
|
Postoperative urinary leakage is defined as the postoperative perirenal drainage volume being greater than 50 ml for 7 consecutive days and the creatinine level of the drainage fluid being similar to that of urine(μmol/L), or postoperative urinary leakage being suspected by imaging examination.
|
the postoperative perirenal drainage volume being greater than 50 ml for 7 consecutive days and the creatinine level of the drainage fluid being similar to that of urine(μmol/L), or postoperative urinary leakage being suspected by imaging examination.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 18, 2024
Primary Completion (Estimated)
September 18, 2025
Study Completion (Estimated)
September 18, 2025
Study Registration Dates
First Submitted
February 24, 2025
First Submitted That Met QC Criteria
April 1, 2025
First Posted (Estimated)
April 8, 2025
Study Record Updates
Last Update Posted (Estimated)
April 8, 2025
Last Update Submitted That Met QC Criteria
April 1, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRCTA,ECFAH OfFMU[2024]905
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial Nephrectomy
-
270SurgicalNot yet recruitingLaparoscopy | Nephrectomy | Partial NephrectomyIsrael
-
Distalmotion SACompletedHysterectomy | Partial Nephrectomy | Right ColectomySwitzerland, Germany, France
-
The Cleveland ClinicTerminated
-
Integra LifeSciences CorporationCompletedBenign, Malignant Tumors or Other Soft Tissue Removal | Nephrectomy or Partial Nephrectomy With Parenchyma RemovalGermany, Italy
-
Milton S. Hershey Medical CenterTerminatedNephrectomy | Partial Nephrectomy | Incision Site DiscomfortUnited States
-
Yonsei UniversityCompletedthe Patients With Partial NephrectomyKorea, Republic of
-
RWTH Aachen UniversityGerman Research FoundationCompleted
-
Intuitive SurgicalRecruitingHernia, Inguinal | Hernia, Ventral | Colorectal | Thoracic | Partial Nephrectomy | GynecologicUnited States
-
The Netherlands Cancer InstituteCompleted
-
EgymedicalpediaCompleted